Literature DB >> 2759487

Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus.

P D James1, M Atkinson.   

Abstract

DNA image cytometry was performed on Feulgen stained sections from 91 biopsies obtained during prospective endoscopic surveillance of 55 patients with Barrett's oesophagus. Aneuploid cells were detected in specimens from six of these patients. Four subsequently developed dysplasia and adenocarcinoma but, in the other two, biopsies had been reported as showing specialised epithelium only, with no apparent dysplasia and no evidence of malignancy on clinical follow up to date. In two of the four patients who subsequently developed carcinoma, aneuploid cells were only found in biopsies showing overt dysplasia or carcinoma but in the two other patients aneuploid cells were present in biopsies taken early in the clinical course before any dysplasia had been identified on the original reports. The presence of aneuploid cells on cytometry of these 'benign' biopsies allowed us, on histological review, to identify areas of atypia which were interpreted as mild dysplasia. In this series aneuploidy was always associated with some morphological abnormality varying from mild dysplasia to frank carcinoma. Aneuploid cells were not shown in material from one patient who had an oesophagectomy for dysplasia or in biopsy material from four patients showing 'indefinite dysplasia'. DNA cytometry combines an objective assessment of epithelial atypia with the advantage of detecting rare cellular aneuploidy and the ability to correlate these events with morphology. It should assist in the more accurate diagnosis of dysplasia and prove useful in identifying those patients with Barrett's oesophagus who are at greater risk of subsequently developing malignancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759487      PMCID: PMC1434272          DOI: 10.1136/gut.30.7.899

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Flow cytometric analysis of deoxyribonucleic acid content in the gastrointestinal tract. Is aneuploidy more than a new ploy?

Authors:  D J Ahnen
Journal:  Gastroenterology       Date:  1987-07       Impact factor: 22.682

Review 2.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

3.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

4.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

5.  Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): a prospective biopsy study.

Authors:  M Peuchmaur; F Potet; D Goldfain
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

6.  Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.

Authors:  R G Lee
Journal:  Am J Surg Pathol       Date:  1985-12       Impact factor: 6.394

7.  Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy.

Authors:  A Böcking; C P Adler; H H Common; M Hilgarth; B Granzen; W Auffermann
Journal:  Anal Quant Cytol       Date:  1984-03

8.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.

Authors:  B J Reid; R C Haggitt; C E Rubin; P S Rabinovitch
Journal:  Gastroenterology       Date:  1987-07       Impact factor: 22.682

9.  The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus.

Authors:  S R Hamilton; R R Smith
Journal:  Am J Clin Pathol       Date:  1987-03       Impact factor: 2.493

10.  Flow cytometric analysis of the DNA content of gastric cancer.

Authors:  K C Ballantyne; P D James; R A Robins; R W Baldwin; J D Hardcastle
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

View more
  8 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Gastroenterology.

Authors:  L J O'Donnell; E M Alstead; M J Farthing
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

3.  Flow cytometry in Barrett's esophagus. What have we learned so far?

Authors:  H S Garewal; R E Sampliner; M B Fennerty
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

4.  Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus.

Authors:  S Y Iftikhar; R J Steele; S Watson; P D James; K Dilks; J D Hardcastle
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

5.  Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.

Authors:  M Miros; P Kerlin; N Walker
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

6.  DNA analysis with flow cytometry and image cytometry in colorectal polyps.

Authors:  F Torresan; L Zanella; A Mattarozzi; A Quiroga; P Bacchini; F Bertoni; L Gandolfi
Journal:  Surg Endosc       Date:  1994-12       Impact factor: 4.584

7.  DNA index determination with Automated Cellular Imaging System (ACIS) in Barrett's esophagus: comparison with CAS 200.

Authors:  Qin Huang; Chenggong Yu; Michael Klein; James Fang; Raj K Goyal
Journal:  BMC Clin Pathol       Date:  2005-08-12

Review 8.  Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.

Authors:  John M Findlay; Mark R Middleton; Ian Tomlinson
Journal:  Dig Dis Sci       Date:  2015-10-07       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.